Parents of children with Autism Spectrum Disorder (ASD) face challenges in finding suitable treatment options. However, there is potential for cannabis oil to offer a solution, as a clinical trial
Research conducted by US scientists has been published, indicating that smoking cannabis does not appear to result in a higher risk of chronic obstructive pulmonary disease (COPD), even among individuals
Cann Group’s losses more than doubled during the first half of the 2023 financial year due to significant increases in administrative, corporate, and research and development expenses. About the Author
There has been significant campaigning this week in Australia regarding the reform of driving laws that impact patients using medical cannabis. About the Author Our deep love of plants and
Recent findings from the Lambert Initiative at the University of Sydney reveal that the majority of Australians still utilize illegal cannabis for medicinal purposes, although there has been a substantial
Greg Barns, spokesperson for the Australian Lawyers Alliance, asserts that the escalating usage of medicinal cannabis in Australia necessitates immediate reforms in legislation to keep up with the evolving situation.
AusCann Group Holdings Limited, an Australian cannabis company has started designing a clinical trial in which will test cannabis medicinal products on those with spinal injuries.
MedReleaf Australia has announced that it plans to make its medicinal cannabis products more accessible to Australians who are in a disadvantaged position, lowering some of their product costs.
The Green Organic Dutchman, whose headquarters are situated in Ontario, Canada, have just shipped over the first shipment of cannabis for the Australian medical cannabis market.
With CBD being approved by Australia’s regulatory system to be sold over the counter in pharmacies, many people are wondering how it works and whether there are any side effects to be advised of.
FreshLeaf Analytics, an industry consultancy says that cannabis could soon be on the mainstream market as more doctors and business are changing their attitudes towards CBD and medical cannabis.
ECS Botanics, a medical cannabis company in Australia has recorded its best ever quarter, generating around $900,000 last quarter, giving a 123% increase from the previous quarter.
Since being legalised in 2016, Australia has seen one of the biggest rises in medical cannabis prescriptions being approved by the Therapeutic Goods Administration’s Special Access Scheme.
Proposed laws in South Australia are said to be unfair to drivers, who could have their licence taken away after using prescribed medical cannabis. The same is not true for those taking opioids and other prescribed meds.
Findings by the University of South Australia found that whilst cannabis use in Australia rose across all states during the first lockdown, methamphetamine use dropped significantly.
As attitudes to cannabis gradually change throughout Australia, thousands of residents have signed a petition calling for the decimalisation of the drug. The petition calls for it to be downgraded to a Schedule 3 substance from a Schedule 8.
CBD oil has become popular around the world for its variety of medicinal side effects and therapies. But what exactly is this magical, therapeutic oil and is it yet legal within Australia?
What exactly is the Cannabis Entourage Effect, and how is Australian research and how this research could decide how the entourage effect can be used in pharmacies.
2021 will see more products being made available on the medicinal cannabis market withing Australia, with the medical sector leading the way for cannabis treatments.
Australian cannabis company Little Green Pharma (LGP) has received another large order for this year, to export medicinal cannabis products to Europe. The demand for cannabis exportation is growing rapidly.
In the US pets like dogs and cats are being treated with cannabis medication, for much the same reasons as humans, such as pain and seizures. But is Australia being slow on the uptake?
Dr Meghan Thomas explains why new research for medicinal cannabis is so important, what her role is with the medicinal cannabis industry and future research studies in development.
The Lambert Initiative for Cannabinoid Therapeutics and the Sydney Pharmacy School at the University of Sydney are surveying pharmacists to see if they are ready for medical cannabis prescriptions.
The latest budget from the Australian Federal Government contains $1.5 million for a trial looking in to personalised medicinal cannabis dosing in cancer patients.
Neurotech International Limited (ASX:NTI) is opening a clinical study trial in 20 children aged between 5-17 years, who have Autism Spectrum Disorder (ASD).
For the first time, a medicinal cannabis drug has been listed on the Australian Pharmaceutical Benefits Scheme (PBS). This means that those who suffer from dravet syndrome, a rare form of epilepsy, can get treatment.
The legislation around cannabis in Australia is slowly changing. Still, laws at the federal level and state level can be both inflicting and confusing. So, what are you allowed to do within Australia?
The first ever medicinal cannabis medication is soon to be on the Pharmaceutical Benefits Scheme, which will help with children suffering from a rare form of epilepsy (Dravet syndrome).
Medicinal cannabis on the Pharmaceutical Benefits Scheme (PBS) will be one of the debates at the Country Women’s Association (CWA) State Conference, which is held in Bega. The annual event will call for cannabis reform.
Views around cannabis, particularly in treating various ailments and disorders are rapidly changing. This article looks at what exactly medical cannabis is, what treatments are available within Australia and how they are taken.